OCS-01, an eye drop developed by Oculis Holding and currently under phase 3 trials for diabetic macular edema (DME), can be an alternative to a medication that is injected into the eye ...

Age-related macular degeneration (AMD ... has developed a new therapeutic agent for dry AMD that can be administered as eye drops. Eye drops are the most preferred drug delivery method in the ...

Age-related macular degeneration (AMD ... has developed a new therapeutic agent for dry AMD that can be administered as eye drops. The work is published in the journal Advanced Science.

Diabetic macular ... in your eye before you experience changes in your vision. There are treatments to slow the progression of DME and prevent further vision loss. Diabetic macular edema (DME ...

Age-related macular degeneration (AMD ... has developed a new therapeutic agent for dry AMD that can be administered as eye drops. Eye drops are the most preferred drug delivery method in the ...